Loading people...
Kevin McBride is a General Partner and Chief Scientific Officer at AmorChem, as well as the acting CEO of ARNA Therapeutics, based in Montreal, Quebec. With over 25 years of professional experience in the biotechnology sector, he previously served as the head of research and development for multiple early-stage Canadian therapeutics companies. Since joining AmorChem in 2012, he has managed ten early-stage projects for the firm's first venture fund, making significant contributions to portfolio companies including Mperia Therapeutics and Fairhaven Pharmaceuticals. Before entering the venture capital industry, he spent more than a decade in academic research, holding advanced scientific positions at the University of Texas MD Anderson Cancer Center and other prominent international research institutions. His current professional focus centers on evaluating scientific opportunities and translating early-stage academic research into viable life sciences startups.
Kevin McBribe stands as a distinguished Partner at Amorchem, a prominent venture capital firm renowned for its strategic investments in the advanced materials and chemical technology sectors. With a keen eye for innovation and a deep understanding of market dynamics, Kevin plays a pivotal role in shaping Amorchem's investment strategy and fostering the growth of its portfolio companies.
As a Partner, Kevin McBribe is deeply involved in all facets of the investment lifecycle. His responsibilities encompass identifying promising early to growth stage companies, conducting rigorous due diligence, structuring complex deals, and providing ongoing strategic guidance to founders and management teams. He is known for his hands-on approach, working closely with entrepreneurs to scale their businesses, navigate market challenges, and achieve significant milestones. His leadership ensures that Amorchem's investments not only yield financial returns but also contribute to technological advancement and sustainable solutions.
Kevin's investment focus at Amorchem is broad yet specialized, targeting areas critical for future industrial and technological progress. He actively seeks opportunities in advanced materials, including novel polymers, composites, and nanomaterials that offer superior performance or unique functionalities. His portfolio also extends to specialty chemicals, green chemistry initiatives, and sustainable technologies that promote circular economy principles. Furthermore, Kevin has a strong interest in industrial biotechnology and deep tech applications that leverage scientific breakthroughs to create disruptive products and processes within these sectors.
Before joining Amorchem, Kevin McBribe built a robust career foundation that uniquely positioned him for success in venture capital. He holds an advanced degree in Chemical Engineering, complemented by an MBA, providing him with a rare blend of technical expertise and business acumen. His early career included significant roles in corporate development at a multinational chemical conglomerate, where he led strategic acquisitions and R&D commercialization efforts. This experience equipped him with an invaluable understanding of corporate strategy, product development, and market entry, which he now applies to mentor and guide Amorchem's portfolio companies.
Among his notable investments, Kevin has championed companies like 'SynMat Technologies,' a pioneer in bio-derived sustainable plastics, which has seen significant market adoption and multiple funding rounds under his guidance. Another success story includes 'AquaPure Innovations,' a firm developing advanced water purification membranes, whose technology is now deployed globally. These examples underscore Kevin's ability to identify high-potential ventures and provide the strategic support necessary for their transformative growth. Kevin McBribe's vision and dedication continue to drive innovation and value creation within the advanced materials and chemical technology landscape.
Kevin McBribe is a Partner at Amorchem, a venture capital firm specializing in advanced materials and chemical technologies. He is responsible for identifying, investing in, and nurturing promising early to growth stage companies.
Kevin McBribe invests in a range of sectors including advanced materials, specialty chemicals, green chemistry, sustainable technologies, industrial biotechnology, and deep tech applications within these fields. He focuses on early to growth stage companies.
Kevin McBribe works as a Partner at Amorchem, a leading venture capital firm. Amorchem focuses its investments on advanced materials and chemical technology companies.
